Apellis Pharmaceuticals (APLS) Q4 2025 Earnings

30OctConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.74
0.06
0.87
1.67

Details

Expected EPS
1.578675
Actual EPS
1.67
Surprise EPS
0.09
Surprise Percent
+5.78%

Description

Apellis Pharmaceuticals (APLS) has reported earnings of 1.67 per share for Q4 2025.

0 Comments

Share your thoughts